Özcan Başaran is an expert in Cardiology at Muğla University (Turkey). Özcan Başaran has authored 140 publications, the most recent in 2026, and is an investigator in 9 clinical trials. SLR score: 389 (community average: 125). How the SLR is computed.

LeadR Profile

Özcan Başaran Muğla University Turkey
389 ScienceLeadR Reputation 389
Network Map

Cardiology

Subspecialties: Public Health - Pharmacy - Endocrinology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026

Source: PubMed

Muğla University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 140

Citations

Citations: 905 1st author: 35 Last author: 6 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Sex differences and gender-related factors in the management and perception of LDL-cholesterol in ASCVD: Real-Life evidence from the EPHESUS registry in cardiology practice.
PMID 42740813 — registries, cholesterol, ldl, perception, cardiology, cholesterol, physicians, sex characteristics, sex, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, education, sex differences
Atheroscler Plus20260
Divergent management of a distal left main coronary artery aneurysm presenting as non-ST-elevation myocardial infarction: surgical vs. medical strategy in two cases-a case report.
PMID 42695064 — myocardial infarction, heart, aneurysm, arteries, st elevation myocardial infarction, coronary artery bypass, therapeutics, non-st elevated myocardial infarction
Eur Heart J Case Rep20260
Impact of Age on Bleeding, Stroke, and Mortality in Edoxaban-Treated Patients with Atrial Fibrillation: Results from the ETAF-TR Registry.
PMID 42455491 — registries, comorbidity, mortality, hemorrhage, ischemic stroke, stroke, pharmaceutical preparations, drug therapy, atrial fibrillation, aged, covid-19, edoxaban
Drugs Aging20260
First quinquennium completed: highlights from EHJ Open 2025.
PMID 42146872
Eur Heart J Open20260
Knowledge and awareness of nonvalvular atrial fibrillation and anticoagulant therapy: Association with medication adherence in a cross-sectional survey.
PMID 41223899 — anticoagulants, cross-sectional studies, atrial fibrillation, cardiology, medication adherence, therapeutics
Int J Cardiol20250

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 9

By status:

Completed 5
Unknown 4

By type:

Observational 8
Interventional 1

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map